4.135
price up icon3.89%   0.155
after-market Handel nachbörslich: 4.14 0.005 +0.12%
loading

Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 0.102
Operating Expenses
23.42%
7.902
10.32 8.861 9.579 9.633
Interest Income/Expense
4.01%
0.646
0.673 0.669 0.644 0.609
Operating Income/Loss
23.42%
-7.902
-10.32 -8.861 -9.579 -9.633
Nonoperating Income/Loss
58.94%
-0.319
-0.777 0.426 -0.035 0.838
Income/Loss From Continuing Operations Before Tax
25.90%
-8.221
-11.10 -8.435 -9.614 -8.795
Income/Loss From Continuing Operations After Tax
25.90%
-8.221
-11.10 -8.435 -9.614 -8.795
Net Income/Loss
25.90%
-8.221
-11.10 -8.435 -9.614 -8.795
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
188.53K%
29.20
0.0155 28.92 28.92 28.92
Diluted Average Shares
188.53K%
29.20
0.0155 28.92 28.92 28.92
Basic Earnings Per Share
26.32%
-0.28
-0.38 -0.29 -0.33 -0.30
Diluted Earnings Per Share
26.32%
-0.28
-0.38 -0.29 -0.33 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):